Male Pattern Hair Loss? Join the Awaken Clinical Trial 

A New Approach to Hair Regrowth Research

Receive up to $4,650 for Time & Travel

Man touching his hairline to inspect thinning hair, looking concerned

Are you noticing more scalp when you look in the mirror? Your hat fits a little looser, and the shower drain collects more hair than it used to. If you are experiencing Androgenetic Alopecia (AGA), also called male pattern hair loss, you are not alone. You deserve clear information, respectful research options, and a study that prioritizes participant safety. No insurance or proof of residency required. Study-related care at no cost. Compensation for time and travel may be available.

Man sitting with his back to the camera as a healthcare professional in blue scrubs hands him paperwork in a medical clinic or exam room.

Let's Grow Together

Cahaba Clinical Research is enrolling men for the Awaken Clinical Trial, a study evaluating an investigational topical gel that targets hair follicles to determine whether it may help promote hair regrowth. This study combines careful science with a participant-centered approach. You will complete thorough screening, receive regular monitoring, and get clear guidance at every visit. There is no cost to participate, and qualified participants may receive up to $4,650 for their time & travel.

Call Today to see if you qualify or fill out the form below.
Space is limited and you can receive up to $4,650

No Insurance or proof of citizenship is required.

CALL (205) 778-1564
Sign Up Today
Clenched close-up of a balding man’s scalp being examined by gloved hands, suggesting a medical hair loss check

The Study Includes

  • An investigational topical gel applied once daily to affected scalp areas
  • A protocol designed to study potential activation of follicle stem cells that play a role in hair growth
  • No insurance required; study-related care at no cost
  • Qualified participants may receive up to $4,650 for your time & travel if you qualify and enroll
Join volunteers contributing to knowledge that may shape future options for AGA.

Signing Up is Simple

Cahaba Clinical Research needs good, reliable participants like you for this study, so that the investigational medicines can be developed and introduced for public use. Look how easy we make it for you to join our team.

Here is all that’s required:

1. Fill Out the Short Form

You will be asked to answer a few basic questions.

2. Receive Our Phone Call

One of our recruiters will call you to discuss your specific skin condition.

3. Come in for an Appointment

At this in-person meeting, we will determine whether you qualify.

4. Join Our Clinical Study

You and your co-volunteers will receive treatments and more.

5. Receive Compensation

Receive up to $4,650 for your time and travel

Man holding his hair at the crown, exposing thinning scalp visible between the fingers.

Why Participate

  • Contribute to scientific progress; help researchers evaluate a potential new approach for Androgenetic Alopecia
  • Access to study-related care, including evaluations, scalp assessments, and monitoring at no cost
  • Oversight by FDA-governed research with IRB review conducted by experienced investigators
  • Respect for your time; qualified participants may receive compensation for time and travel
  • A professional team attentive to privacy and your questions
Back view of a man wearing a dark T-shirt, hands on his bald crown, seen from behind.

Criteria To Qualify

You may qualify if you:

  • Are male, between 18 and 55 years old
  • Have been diagnosed with Androgenetic Alopecia for at least 6 months
  • Have not undergone a hair transplant or surgical hair restoration
Additional inclusion and exclusion criteria apply. The research team will review eligibility during screening. We may discuss current hair length requirements and scalp area assessments at your visit.
Man in a mauve long-sleeve shirt runs his hands through his dark hair, looking thoughtfully to the side against a blue background.

About the Study

The Awaken Trial is evaluating an investigational topical gel for AGA. Researchers are studying its safety and whether it may help promote hair regrowth. The investigational treatment has not been approved for AGA or any other condition.
Dental professional in PPE examines a male patient under an overhead dental lamp in a clinic.

Cahaba Clinical Research

Cahaba Clinical Research conducts FDA-governed, IRB-reviewed dermatology studies led by experienced investigators, including board-certified leadership. The team prioritizes participant safety, privacy, and clear communication.
  • Investigators with extensive experience in dermatology studies.
  • Responsible, science-forward methodologies
  • HIPAA-compliant confidentiality and respectful communication
  • Clear instructions, regular monitoring, and consistent follow-up

Join the Awaken Trial screening. Small steps today can support meaningful progress for AGA research.

What People Are Saying About "Cahaba Clinical Research"

Five gold stars in a row representing a perfect rating on a black background, a five-star rating display.
Great doctors and nurses. Love it here
Colin S.
Five gold stars in a row representing a perfect rating on a black background, a five-star rating display.
Absolutely the best staff ever.
Stacie L.

Cahaba Clinical Trials -
Your Trusted Source for
" Tomorrow’s Medicines Today "

The experienced, compassionate staff at Cahaba Clinical Trials will be with you every step of the way through this trial. They understand how important it is that you understand every step of the trial and are there to answer your every question. They have been helping people just like you for years bringing relief to you and thousands like you through these clinical trials. Don’t wait another minute to call or fill out a form, your chronic atopic dermatitis is not waiting and this may be the answer to end your suffering.

CALL (205) 778-1564
Your Name
Consent

Frequently Asked Questions

What is Androgenetic Alopecia (AGA)?

Androgenetic Alopecia, often called male pattern hair loss, is a common form of hair thinning that typically presents with a receding hairline or crown thinning due to genetic and hormonal factors.
Men ages 18 to 55 with AGA for at least 6 months may qualify. Additional inclusion and exclusion criteria apply and will be reviewed during screening.
The gel is being studied for its potential to activate follicle stem cells that play a role in hair growth. Its safety and effectiveness have not been established.
Participants apply the investigational or placebo gel once daily to affected areas of the scalp as directed by the study team.
Participation lasts about one year, including screening, run-in, treatment, long-term extension, and a safety follow-up call.
Participants have a 75 percent chance of receiving the investigational treatment at some point during the study.
There is no guarantee of benefit or cure. The study aims to evaluate safety and potential effectiveness for hair regrowth outcomes.
There is no cost for study-related care, evaluations, or the study gel. Qualified participants may receive compensation for time and travel.
No. Insurance is not required to participate.
Yes. Participation is voluntary. You may withdraw at any time after speaking with the study doctor about a safe discontinuation plan.
Visits include health assessments, scalp and hair evaluations, review of your electronic diary, and study medication accountability, all at no cost.
Qualified participants who enroll may receive up to $4,650 for time and travel. The study team will explain details during consent.
All medications can have risks. Potential side effects will be discussed during informed consent. Safety is closely monitored throughout the study.
Some products or procedures may not be allowed during the trial. The study team will review allowed and restricted treatments at screening.
Individuals with prior hair transplants or surgical restoration are not eligible for this trial.
Eligibility includes a clinical assessment of pattern hair loss. The research team will confirm diagnosis and severity during screening.
AGA commonly affects the temples, hairline, and crown. Patterns and severity vary by individual.
Responses vary. Some participants may notice changes over months. The trial evaluates outcomes at planned time points across the year.
A placebo gel has no active ingredient. Comparing investigational gel to placebo helps researchers assess safety and potential effectiveness.
An Institutional Review Board reviews the protocol to help protect participant rights and welfare during the study.
Yes. Androgenetic Alopecia is commonly called male pattern hair loss or male pattern baldness.
Lifestyle changes alone typically do not reverse AGA. Research explores investigational options that may influence hair growth outcomes.
Participants must wait at least two hours after applying the gel before showering, swimming, or wearing a hat. An approved non-medicated shampoo may be used.
Approximately 12 visits are planned across the study. Your schedule will be reviewed and confirmed by the research team.
Your information is handled under HIPAA-compliant procedures. Privacy and confidentiality are prioritized.
This specific trial enrolls male participants ages 18 to 55. Separate studies may be available for female pattern hair loss.
Tell the study team right away. Safety is monitored throughout, and the investigator will guide next steps based on the protocol.
AGA is influenced by genetics and hormonal factors. Family history can play a role in pattern and onset.
Visit our website to complete the online screening, or call 205-778-1564 to speak with our team.
No insurance or proof of residency is required. The team will guide you through consent and study requirements.